Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review

The current gold standard to prevent allograft rejection for maintenance immunosuppression in kidney transplantation currently consists in glucocorticoids, an antiproliferative agent and a calcineurin inhibitor (CNI), with better outcome for tacrolimus than cyclosporin. Although, CNI drastically imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Yannis, François, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329606/
https://www.ncbi.nlm.nih.gov/pubmed/35911396
http://dx.doi.org/10.3389/fmed.2022.942665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329606/
https://www.ncbi.nlm.nih.gov/pubmed/35911396
http://dx.doi.org/10.3389/fmed.2022.942665

Ejemplares similares